Literature DB >> 25176984

Remission status should not be treated as a base-line covariate--reply to Etienne et al.

Michael Lauseker1, Joerg Hasford2.   

Abstract

Keywords:  Kaplan-Meier; base-line covariate; remission status

Mesh：

Substances：

Year:  2014        PMID： 25176984      PMCID： PMC4562554          DOI： 10.3324/haematol.2014.108951

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  The impact of time-dependent bias in proportional hazards modelling.

Authors:  Jan Beyersmann; Martin Wolkewitz; Martin Schumacher
Journal:  Stat Med       Date:  2008-12-30       Impact factor: 2.373

2.  Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia.

Authors:  M Pfirrmann; A Hochhaus; M Lauseker; S Saussele; R Hehlmann; J Hasford
Journal:  Leukemia       Date:  2011-05-20       Impact factor: 11.528

3.  Responder versus nonresponder comparisons: daunorubicin plus prednisone in treatment of acute nonlymphocytic leukemia.

Authors:  N Mantel
Journal:  Cancer Treat Rep       Date:  1983-03

4.  Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy.

Authors:  Gabriel Etienne; Stéphanie Dulucq; Franck-Emmanuel Nicolini; Stéphane Morisset; Marie-Pierre Fort; Anna Schmitt; Madeleine Etienne; Sandrine Hayette; Eric Lippert; Caroline Bureau; Isabelle Tigaud; Didier Adiko; Gérald Marit; Josy Reiffers; François-Xavier Mahon
Journal:  Haematologica       Date:  2013-12-20       Impact factor: 9.941

5.  A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias.

Authors:  R Simon; R W Makuch
Journal:  Stat Med       Date:  1984 Jan-Mar       Impact factor: 2.373

6.  Analysis of survival by tumor response.

Authors:  J R Anderson; K C Cain; R D Gelber
Journal:  J Clin Oncol       Date:  1983-11       Impact factor: 44.544

7.  Impact of treatment end point definitions on perceived differences in long-term outcome with tyrosine kinase inhibitor therapy in chronic myeloid leukemia.

Authors:  Hagop Kantarjian; Susan O'Brien; Elias Jabbour; Jenny Shan; Farhad Ravandi; Tapan Kadia; Stefan Faderl; Guillermo Garcia-Manero; Gautam Borthakur; Jorge Cortes
Journal:  J Clin Oncol       Date:  2011-07-11       Impact factor: 44.544
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.